White blood cell count is associated with incident cardio-renal complications in Chinese patients with type 2 diabetes

被引：0
|
作者：
Tam, C. H. T. [1 ]
Luk, A. O. Y. [1 ]
Kong, A. P. S. [1 ]
Ozaki, R. [1 ]
So, W. -Y. [1 ]
Chan, J. C. N. [1 ]
Ma, R. C. W. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
297
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] Elevated white blood cell count predicts type 2 diabetes in Pima Indians
    Vozarova, B
    Weyer, C
    Wilson, C
    Pratley, RE
    Tataranni, PA
    DIABETES, 2001, 50 : A536 - A536
  • [22] Correlation Between White Blood Cell Count and Insulin Resistance in Type 2 Diabetes
    Mandiani, Armin
    Kheirandish, Masoume
    Bonakdaran, Shokoufeh
    CURRENT DIABETES REVIEWS, 2019, 15 (01) : 62 - 66
  • [23] Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
    Parving, Hans-Henrik
    Brenner, Barry M.
    McMurray, John J. V.
    de Zeeuw, Dick
    Haffner, Steven M.
    Solomon, Scott D.
    Chaturvedi, Nish
    Persson, Frederik
    Nicolaides, Maria
    Richard, Alexia
    Xiang, Zhihua
    Armbrecht, Juergen
    Pfeffer, Marc A.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2012, 13 (03) : 387 - 393
  • [24] IMPAIRED RED BLOOD CELL DEFORMABILITY IS ASSOCIATED WITH DIABETIC COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES
    Moon, J. S.
    Kyoung, K. Yu
    Chang, W. Kyu
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A53 - A53
  • [25] Blood pressure reduction in diabetic patients with cardio-renal complications. Results from the 3A registry
    Lehmann, M. V.
    Dechend, R.
    Kaiser, E.
    Deeg, E.
    Senges, J.
    Zeymer, U.
    Schmieder, R. E.
    EUROPEAN HEART JOURNAL, 2011, 32 : 888 - 888
  • [26] Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany
    Kaehm, Katharina
    Laxy, Michael
    Schneider, Udo
    Rogowski, Wolf H.
    Lhachimi, Stefan K.
    Holle, Rolf
    DIABETES CARE, 2018, 41 (05) : 971 - 978
  • [27] Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
    Parving, Hans-Henrik
    Brenner, Barry M.
    McMurray, John. J. V.
    de Zeeuw, Dick
    Haffner, Steven M.
    Solomon, Scott D.
    Chaturvedi, Nish
    Ghadanfar, Mathieu
    Weissbach, Nicole
    Xiang, Zhihua
    Armbrecht, Juergen
    Pfeffer, Marc A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (05) : 1663 - 1671
  • [28] Sex Differences in Glutathione Peroxidase Activity and Central Obesity in Patients with Type 2 Diabetes at High Risk of Cardio-Renal Disease
    Steyn, Mia
    Zitouni, Karima
    Kelly, Frank J.
    Cook, Paul
    Earle, Kenneth A.
    ANTIOXIDANTS, 2019, 8 (12)
  • [29] Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
    Nashawi, Mouhamed
    Sheikh, Omar
    Battisha, Ayman
    Ghali, Abdullah
    Chilton, Robert
    HEART FAILURE REVIEWS, 2021, 26 (03) : 643 - 652
  • [30] Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
    Mouhamed Nashawi
    Omar Sheikh
    Ayman Battisha
    Abdullah Ghali
    Robert Chilton
    Heart Failure Reviews, 2021, 26 : 643 - 652
12345